These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9120470)

  • 21. Malignant osteopetrosis: hypercalcaemia after bone marrow transplantation.
    Rawlinson PS; Green RH; Coggins AM; Boyle IT; Gibson BE
    Arch Dis Child; 1991 May; 66(5):638-9. PubMed ID: 2039258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combination therapy with pamidronate and calcitonin in hypercalcemic crisis caused by primary hyperparathyroidism].
    Christensen JH; Kristiansen JH
    Ugeskr Laeger; 1992 Nov; 154(47):3341-2. PubMed ID: 1462441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous pamidronate sodium therapy in immobilization-related hypercalcemia.
    Tamion F; Bonmarchand F; Girault C; Chevron V; Leroy J
    Clin Nephrol; 1995 Feb; 43(2):138-9. PubMed ID: 7736680
    [No Abstract]   [Full Text] [Related]  

  • 24. The management of malignant hypercalcaemia.
    Watters J; Gerrand G; Dodwell D
    Drugs; 1996 Dec; 52(6):837-48. PubMed ID: 8957154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant hypercalcaemia in pregnancy and antenatal administration of intravenous pamidronate.
    Illidge TM; Hussey M; Godden CW
    Clin Oncol (R Coll Radiol); 1996; 8(4):257-8. PubMed ID: 8871006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The pharmacology of biphosphonates and their use in hypercalcemia].
    Adam Z; Vorlícek J; Tomíska M
    Vnitr Lek; 1994 Oct; 40(10):667-70. PubMed ID: 7810087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disodium pamidronate, bisphosphonate for malignant hypercalcaemia.
    Cantwell BM
    Ir Med J; 1990 Mar; 83(1):32-4. PubMed ID: 2193900
    [No Abstract]   [Full Text] [Related]  

  • 28. Pamidronate for cancer-associated hypercalcemia.
    Anand A; Anand N
    Arch Intern Med; 1995 Mar; 155(6):641-2, 645. PubMed ID: 7887762
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of hypercalcemia of malignancy with pamidronate in a patient with advanced recurrent oral cancer].
    Nishimura N; Matsushita Y; Takaoka K; Hashitani S; Noguchi K; Urade M
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2537-9. PubMed ID: 12506478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative tolerability of drug therapies for hypercalcaemia of malignancy.
    Zojer N; Keck AV; Pecherstorfer M
    Drug Saf; 1999 Nov; 21(5):389-406. PubMed ID: 10554053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
    Jansson S; Tisell LE; Lindstedt G; Lundberg PA
    Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children.
    Schmid I; Stachel D; Schön C; Bauer M; Haas RJ
    Klin Padiatr; 2001; 213(1):30-4. PubMed ID: 11225473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abdominal symptoms, hypercalcaemia and apathetic hyperthyroidism: treatment with pamidronate.
    Ghose RR; Palmer DJ; Yaqoob M; Haboubi N; Ratcliffe WA
    Br J Clin Pract; 1994; 48(3):163-4. PubMed ID: 8031697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of bisphosphonates for resistant hypercalcemia in children with acute lymphoblastic leukemia: report of two cases and review of the literature.
    Andiran N; Alikaşifoğlu A; Küpeli S; Yetgin S
    Turk J Pediatr; 2006; 48(3):248-52. PubMed ID: 17172070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypercalcaemia in primary oxalosis: role of increased bone resorption and effects of treatment with pamidronate.
    Yamaguchi K; Grant J; Noble-Jamieson G; Jamieson N; Barnes ND; Compston JE
    Bone; 1995 Jan; 16(1):61-7. PubMed ID: 7742085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate.
    Cagle AP; Waguespack SG; Buckingham BA; Shankar RR; Dimeglio LA
    Pediatrics; 2004 Oct; 114(4):1091-5. PubMed ID: 15466114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastatic bone disease and tumour-induced hypercalcaemia: the role of bisphosphonates.
    Heatley S
    Int J Palliat Nurs; 2001 Jun; 7(6):301-2, 304-7. PubMed ID: 12066026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficient treatment of hypercalcaemia in neonatal subcutaneous fat necrosis].
    Bergstein KR; Jacobsen RB; Jacobsen BB; Christesen HT
    Ugeskr Laeger; 2010 Jul; 172(29):2096-7. PubMed ID: 20633344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of disodium pamidronate in children with hypercalcemia awaiting liver transplantation.
    Attard TM; Dhawan A; Kaufman SS; Collier DS; Langnas AN
    Pediatr Transplant; 1998 May; 2(2):157-9. PubMed ID: 10082449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
    Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.